Over 4 years (FY 2021 to FY 2025), Research & Development Solutions — Business combinations shows an upward trend with a 25.9% CAGR.
Higher values reflect aggressive investment in expanding service capabilities or geographic reach, while lower values suggest a focus on organic growth or integration consolidation.
Captures the financial impact of integrating newly acquired entities into the research and development solutions segment...
Similar to acquisition-related cash outflows or integration costs reported by peer CROs and healthcare service firms.
iqv_segment_research_development_solutions_business_combinations| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $25.00M | $135.00M | $0.00 | $253.00M | -$16.00M | -$1.00M | $236.00M | $0.00 | $180.00M | $1.00M | $0.00 | $0.00 | $0.00 | $181.00M | $5.00M | $0.00 | $79.00M | $323.00M | $0.00 | $4.00M |
| QoQ Change | — | +440.0% | -100.0% | — | -106.3% | +93.8% | >999% | -100.0% | — | -99.4% | -100.0% | — | — | — | -97.2% | -100.0% | — | +308.9% | -100.0% | — |
| YoY Change | — | — | — | — | -164.0% | -100.7% | — | -100.0% | >999% | +200.0% | -100.0% | — | -100.0% | >999% | — | — | — | +78.5% | -100.0% | — |